441 related articles for article (PubMed ID: 30031954)
1. Progesterone Receptor Is Responsible for Benign Biology of Skull Base Meningioma.
Kuroi Y; Matsumoto K; Shibuya M; Kasuya H
World Neurosurg; 2018 Oct; 118():e918-e924. PubMed ID: 30031954
[TBL] [Abstract][Full Text] [Related]
2. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.
Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M
Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512
[TBL] [Abstract][Full Text] [Related]
3. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
[TBL] [Abstract][Full Text] [Related]
4. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.
Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E
Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138
[TBL] [Abstract][Full Text] [Related]
5. Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.
Savardekar AR; Patra DP; Bir S; Thakur JD; Mohammed N; Bollam P; Georgescu MM; Nanda A
World Neurosurg; 2018 Apr; 112():e74-e83. PubMed ID: 29258946
[TBL] [Abstract][Full Text] [Related]
6. A comparison of clinicopathological features and surgical outcomes between pediatric skull base and non-skull base meningiomas.
Li Z; Li H; Jiao Y; Ma J; Wang S; Zhao J; Cao Y
Childs Nerv Syst; 2017 Apr; 33(4):595-600. PubMed ID: 27796552
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas.
Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K
Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071
[TBL] [Abstract][Full Text] [Related]
8. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
McGovern SL; Aldape KD; Munsell MF; Mahajan A; DeMonte F; Woo SY
J Neurosurg; 2010 May; 112(5):925-33. PubMed ID: 19799498
[TBL] [Abstract][Full Text] [Related]
9. Surgery of Small Anterior Skull Base Meningiomas by Endoscopic 5-Aminolevulinic Acid Fluorescence Guidance: First Clinical Experience.
Cornelius JF; Kamp MA; Tortora A; Knipps J; Krause-Molle Z; Beez T; Petridis AK; Sabel M; Schipper J; Steiger HJ
World Neurosurg; 2019 Feb; 122():e890-e895. PubMed ID: 30419399
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse.
Tao Y; Liang G; Li Z; Wang Y; Wu A; Wang H; Lu Y; Liu Z; Hu G
Br J Neurosurg; 2012 Oct; 26(5):700-4. PubMed ID: 22616825
[TBL] [Abstract][Full Text] [Related]
11. Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases.
Cornelius JF; Slotty PJ; Steiger HJ; Hänggi D; Polivka M; George B
Acta Neurochir (Wien); 2013 Mar; 155(3):407-13. PubMed ID: 23318687
[TBL] [Abstract][Full Text] [Related]
12. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
[TBL] [Abstract][Full Text] [Related]
13. Meningiomas Display a Specific Immunoexpression Pattern in a Rostrocaudal Gradient: An Analysis of 366 Patients.
Ülgen E; Bektaşoğlu PK; Sav MA; Can Ö; Danyeli AE; Hızal DB; Pamir MN; Özduman K
World Neurosurg; 2019 Mar; 123():e520-e535. PubMed ID: 30503291
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic Endonasal Craniofacial Surgery for Recurrent Skull Base Meningiomas Involving the Pterygopalatine Fossa, the Infratemporal Fossa, the Orbit, and the Paranasal Sinus.
Shin M; Shojima M; Kondo K; Hasegawa H; Hanakita S; Ito A; Kin T; Saito N
World Neurosurg; 2018 Apr; 112():e302-e312. PubMed ID: 29339322
[TBL] [Abstract][Full Text] [Related]
15. The role of radical microsurgical resection in multimodal treatment for skull base meningioma.
Ichinose T; Goto T; Ishibashi K; Takami T; Ohata K
J Neurosurg; 2010 Nov; 113(5):1072-8. PubMed ID: 20225926
[TBL] [Abstract][Full Text] [Related]
16. Analysis of factors affecting the long-term functional outcome of patients with skull base meningioma.
Nakao N; Ohkawa T; Miki J; Nishibayahsi H; Ogura M; Uematsu Y; Itakura T
J Clin Neurosci; 2011 Jul; 18(7):895-8. PubMed ID: 21565513
[TBL] [Abstract][Full Text] [Related]
17. [Skull base meningiomas: a predictive system to know the extent of their surgical resection and patient outcome].
Morales F; Maillo A; Díaz-Alvarez A; Merino M; Muñoz-Herrera A; Hernández J; Santamarta D
Neurocirugia (Astur); 2005 Dec; 16(6):477-85. PubMed ID: 16378129
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
[TBL] [Abstract][Full Text] [Related]
19. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
